Literature DB >> 2731078

Production of mutacin-like substances by Streptococcus mutans.

M Parrot1, M Charest, M C Lavoie.   

Abstract

Production of inhibitory substances by strains of the Streptococcus mutans group is well documented, but the nature of the substances implied is often unknown. Of nine laboratory strains known to produce inhibitory substances, the optimal conditions for producing inhibition zones on solid media were found to vary between strains but good production was generally obtained on all-purpose media with Tween 80 at 37 degrees C after 2-4 days of aerobic incubation. Streptococcus sanguis Ny101 was found to be more sensitive than Streptococcus rattus LG-1 to all inhibitory substances produced by the S. mutans strains tested. While all strains showed some inhibition, only six showed inhibition after neutralization; arginine incorporated in agar at 0.75% completely eliminated all inhibition zones. However 1% arginine in the overlays did not affect the production of inhibition zones by strains of S. mutans C67-1, Ny257, Ny266, and T8. These strains were shown to elaborate (in a reproducible fashion) inhibitory substances which were not organic acids. Inhibitory activity was never obtained in liquid preparations, except for strains Ny257 and T8 where it was found to be very unstable.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2731078     DOI: 10.1139/m89-056

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  12 in total

1.  MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens.

Authors:  M Mota-Meira; G LaPointe; C Lacroix; M C Lavoie
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

2.  Antagonistic effect of oral bacteria towards Treponema denticola.

Authors:  D Grenier
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

3.  Mutacin production by Streptococcus mutans may promote transmission of bacteria from mother to child.

Authors:  L Grönroos; M Saarela; J Mättö; U Tanner-Salo; A Vuorela; S Alaluusua
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Optimization of the Production of the Lantibiotic Mutacin 1140 in Minimal Media.

Authors:  Dahal Neeti; Chaney Noel; Ellis Dayna; Lu Shi-En; Smith Leif
Journal:  Process Biochem       Date:  2010-07-01       Impact factor: 3.757

5.  Passive immunization by lactobacilli expressing single-chain antibodies against Streptococcus mutans.

Authors:  Carina Krüger; Anna Hultberg; Craig van Dollenweerd; Harold Marcotte; Lennart Hammarström
Journal:  Mol Biotechnol       Date:  2005-11       Impact factor: 2.695

Review 6.  Oral microbial ecology and the role of salivary immunoglobulin A.

Authors:  H Marcotte; M C Lavoie
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

7.  Production and properties of bacteriocin-like inhibitory substances from the swine pathogen Streptococcus suis serotype 2.

Authors:  D Mélançon; D Grenier
Journal:  Appl Environ Microbiol       Date:  2003-08       Impact factor: 4.792

8.  In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria.

Authors:  Alan J Marsh; Orla O'Sullivan; R Paul Ross; Paul D Cotter; Colin Hill
Journal:  BMC Genomics       Date:  2010-11-30       Impact factor: 3.969

9.  Mutacin H-29B is identical to mutacin II (J-T8).

Authors:  Guillaume Nicolas; Hélène Morency; Gisèle LaPointe; Marc C Lavoie
Journal:  BMC Microbiol       Date:  2006-04-20       Impact factor: 3.605

10.  Mutacins of Streptococcus mutans.

Authors:  Regianne Umeko Kamiya; Tiago Taiete; Reginaldo Bruno Gonçalves
Journal:  Braz J Microbiol       Date:  2011-12-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.